Literature DB >> 3958974

Modification of morphine tolerance by behavioral variables.

C A Sannerud, A M Young.   

Abstract

These experiments assessed whether the opportunity to perform a target operant in the presence of morphine would alter the development of behavioral tolerance. Morphine tolerance was assessed in rats responding under a fixed-ratio 30 schedule of food delivery. Separate groups of rats were administered 10 mg/kg of morphine either pre- or postsession for 9 weeks. The degree of drug tolerance was assessed by determining cumulative dose-response functions for morphine before, during and after chronic administration. Three to 4-fold tolerance to the rate-decreasing effects of morphine developed in rats receiving morphine presession, whereas no tolerance developed in rats receiving an equal dose of morphine postsession. Morphine sensitivity returned to initial values 4 weeks after termination of chronic administration. Eight weeks after termination of chronic administration, the drug-daily session relationship was reversed and the rats were re-exposed to 10 mg/kg of morphine for 9 additional weeks. There were fewer differences between groups receiving morphine pre- or postsession during this second chronic administration phase. During chronic administration of morphine, the dose of naloxone required to suppress response rates decreased 100-fold in rats receiving morphine presession, but only 10-fold in rats receiving morphine postsession. In contrast, chronic administration of morphine did not alter the rate-decreasing effects of the nonopioids d-amphetamine, ketamine or pentobarbital. These experiments suggest that reinforcement of an operant response in the presence of morphine promoted the development of pharmacologically specific behavioral tolerance to morphine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958974

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Situational specificity of tolerance to effects of phencyclidine on responding of rats under fixed-ratio and spaced-responding schedules.

Authors:  J B Smith
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Situational specificity of tolerance to decreased operant responding by morphine and l-nantradol.

Authors:  J B Smith
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Opioid modulation of the discriminative stimulus produced by pentylenetetrazol.

Authors:  M W Emmett-Oglesby; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Tolerance to morphine stimulus control: role of morphine maintenance dose.

Authors:  A M Young; C A Sannerud; E S Steigerwald; M D Doty; W J Lipinski; L E Tetrick
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Evaluation of the effects of opioid agonists and antagonists under a delayed matching-to-sample procedure in pigeons.

Authors:  M Picker; C A Massie; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Environmental modification of tolerance to morphine discriminative stimulus properties in rats.

Authors:  C A Sannerud; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Morphine tolerance as a function of ratio schedule: response requirement or unit price?

Authors:  Christine E Hughes; Stacey C Sigmon; Raymond C Pitts; Linda A Dykstra
Journal:  J Exp Anal Behav       Date:  2005-05       Impact factor: 2.468

8.  Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.

Authors:  M J Picker; S S Negus; K R Powell
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Role of µ-opioid receptor reserve and µ-agonist efficacy as determinants of the effects of µ-agonists on intracranial self-stimulation in rats.

Authors:  Ahmad A Altarifi; Laurence L Miller; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2012-10       Impact factor: 2.293

10.  [Opioids in "non-malignant" pain-results of long-term treatment in patients with rheumatic disease.].

Authors:  J Sorge; B Steffmann; C Lehmkuhl; I Pichlmayr
Journal:  Schmerz       Date:  1991-06       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.